Tickers

ARTNA — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-24 10:18:50.156618 UTC · finished 2026-09-24 10:26:57.757259 UTC

1. Composite Trajectory Verdict

Given ARTNA's regulated utility business model — where earnings are driven by allowed returns on rate base, and capital intensity is high — the income statement and cash flow statement carry the most weight for assessing financial performance, with the balance sheet reflecting the cumulative financing of that investment cycle.

Composite Trajectory: Mixed

Earnings trajectory is clearly improving: annual revenue, operating income, net income, and EPS have grown for three consecutive years, with margins expanding. Cash flow trajectory is mixed: operating cash flow rises annually but free cash flow remains deeply negative and widened in 2025, while the first half of 2026 showed flat operating cash flow year-on-year. Balance sheet trajectory is also mixed: equity and rate base grow steadily, but year-end 2025 liquidity was extremely thin ($52K cash, current ratio 0.64), though improved by June 2026 ($9.8M cash, lines of credit repaid). The overall picture is one of strengthening regulatory earnings offset by persistent capital intensity that outpaces internal cash generation.

2. Red Flags

  • Negative and widening free cash flow: 2025 FCF = -$18.5M (operating cash flow $40.3M less CapEx $58.8M) vs 2024 FCF = -$9.1M (10-K 2025-12-31, Statements of Cash Flows).
  • Year-end 2025 liquidity crisis: Cash of $52K vs $1.1M in 2024; current ratio 0.64 ($21.4M current assets / $33.7M current liabilities) vs 0.96 in 2024 (10-K 2025-12-31, Consolidated Balance Sheets).
  • Dependence on temporary rates with refund risk: As of Dec 31, 2025, a portion of the November 6, 2025 temporary rate increase (6.82%) was reserved for refund and excluded from revenue (10-K 2025-12-31, MD&A, Operating Revenues).
  • Rising CapEx with regulatory recovery lag: Projected 2026 net investment in plant of $64.3M vs 2025 actual of $32.8M (10-K 2025-12-31, Liquidity and Capital Resources, Investment Activities table).
  • PFAS and LCRI compliance costs not yet fully reflected in rates: EPA MCLs effective April 2029 (Delaware notification Jan 2026); LCRI requires lead line removal within 10 years; capital and operating costs anticipated recoverable but timing uncertain (10-Q 2026-06-30, MD&A, Environmental, Health and Safety).
  • H1 2026 operating cash flow flat despite revenue growth: $18.8M vs $18.9M in H1 2025 (10-Q 2026-06-30, MD&A, Liquidity and Capital Resources, Operating Activities).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Overall Assessment: Annual total operating revenue rose from $98.9M (2023) to $108.0M (2024, +9.2%) to $112.9M (2025, +4.6%) (10-K 2025-12-31, Consolidated Statements of Operations). Net income grew from $16.7M to $20.4M (+22.1%) to $22.8M (+11.9%) over the same periods. Operating margin expanded from 22.7% (2023) to 24.2% (2024) to 24.6% (2025); net margin from 16.9% to 18.9% to 20.2%. Six-month results to June 30, 2026 show revenue of $58.4M vs $54.4M in H1 2025 (+7.4%) and net income up 6.7% (10-Q 2026-06-30, MD&A, Results of Operations – Six Months). The ratio of operating expenses (excl. D&A and taxes) to revenue improved to 55.2% in H1 2026 from 55.6% in H1 2025. Growth is driven by customer additions (water +1.8%, wastewater +6.5% YoY as of Dec 2025), temporary rate increases (2.88% June 2025, 6.82% Nov 2025), and DSIC revenue ($0.5M in 2025 vs $0.1M in 2024) (10-K 2025-12-31, MD&A, Operating Revenues; Note 13).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Annual net cash from operations increased steadily: $31.9M (2023) → $36.8M (2024, +15.6%) → $40.3M (2025, +9.6%) (10-K 2025-12-31, Consolidated Statements of Cash Flows). However, capital expenditures remained high ($62.2M, $45.9M, $58.8M), leaving free cash flow negative in all three years and widening to -$18.5M in 2025 from -$9.1M in 2024. Financing cash flows filled the gap: $17.3M in 2025 (vs $7.1M in 2024), driven by $26.1M net developer contributions/advances and $5.7M line-of-credit borrowings (10-K 2025-12-31, Consolidated Statements of Cash Flows). In H1 2026, operating cash flow was essentially flat at $18.8M vs $18.9M in H1 2025, while CapEx was $25.9M vs $26.3M; financing provided $16.7M (vs $6.5M), boosted by a $10M long-term debt issuance for Artesian Water Maryland and $20.3M net developer contributions (10-Q 2026-06-30, MD&A, Liquidity and Capital Resources; Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total assets grew from $798.6M (Dec 2024) to $851.2M (Dec 2025, +6.6%) to $884.0M (June 2026, +3.9% over six months) (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets). Utility plant (net) rose from $747.2M to $801.7M to $825.8M, reflecting continued rate-base expansion. Stockholders' equity increased from $239.2M to $249.9M to $256.2M, supported by retained earnings ($85.0M → $95.1M → $101.1M). Long-term debt was stable at $176.5M → $174.3M → $182.6M (the June 2026 rise includes the new $10M Maryland loan). The debt-to-equity ratio improved from 0.74 to 0.70 to 0.71. Liquidity deteriorated sharply at year-end 2025 (cash $52K, lines of credit drawn $5.7M, current ratio 0.64) but recovered by June 2026 (cash $9.8M, lines of credit $0, current ratio ~1.2). Net contributions in aid of construction (CIAC) grew from $272.4M to $311.1M to $326.8M, reducing net rate-base funding needs (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets).

6. Data Gaps

  • Standalone Q1 2026 vs Q1 2025 income statement and cash flow figures (only six-month and Q2 2026 data provided in 10-Q 2026-06-30 and 10-Q 2026-03-31).
  • Q3 2025 vs Q3 2024 comparative figures (10-Q 2025-09-30 provided but not fully extracted for YoY comparison).
  • Full-year 2026 actuals (only H1 2026 available).
  • Quantitative breakdown of the refund reserve for the November 2025 temporary rate increase (amount not disclosed).
  • Projected operating cash flow for full-year 2026 (only CapEx guidance of ~$64.3M net investment provided).
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status